Abstract

This document provides interim recommendations from the WHO Strategic Advisory Group of Experts (SAGE) on Immunization for influenza vaccination during the COVID-19 pandemic. It also provides programmatic considerations for national authorities planning and conducting their influenza vaccination programmes, as well as research considerations to address current knowledge gaps.

It is important to note that the suggested prioritization in this document should be considered along with the 2012 position paper, national polices, local epidemiology, and the potential for increased demand for influenza vaccines. The interim change in risk groups proposed in this paper is only meant to ensure optimal control of influenza during COVID-19 and should not negatively impact influenza vaccination programmes and coverage of existing target groups, which are based on the national policies and epidemiological situation for both influenza and COVID-19.

  • SAGE